Laddar...
Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis
BACKGROUND: Postoperative docetaxel plus S-1 (DS) chemotherapy is expected to be the standard therapeutic strategy for pStage III gastric cancer based on the results of the JACCRO GC-07 study. Neoadjuvant chemotherapy (NAC) is thought to have several advantages over adjuvant settings. OBJECTIVE: Thi...
Sparad:
| I publikationen: | Ann Surg Oncol |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2019
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6510880/ https://ncbi.nlm.nih.gov/pubmed/30977014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-019-07299-7 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|